Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.08%) 5 331.50 points
Dow Jones Futures
(0.01%) 40 142 points
Nasdaq Futures
(0.13%) 18 659 points
Oil
(-0.06%) $80.01
Gas
(0.53%) $2.64
Gold
(1.12%) $2 444.50
Silver
(2.83%) $32.15
Platinum
(0.36%) $1 093.90
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.08%) $10.67
USD/GBP
(0.01%) $0.787
USD/RUB
(-0.27%) $90.72

Realtime updates for Eupraxia Pharmaceuticals [EPRX.TO]

Exchange: TSX Industry: Biotechnology
Last Updated17 May 2024 @ 15:59
25% discount on Stockinvest.us - Use code: Podcast

1.01% $ 4.00

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 15:59):

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector...

Stats
Today's Volume 32 000.00
Average Volume 63 280.00
Market Cap 142.49M
EPS $0 ( 2024-05-08 )
Next earnings date ( $-0.340 ) 2024-08-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -3.33
ATR14 $0.0160 (0.40%)

Eupraxia Pharmaceuticals Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eupraxia Pharmaceuticals Financials

Annual 2023
Revenue: $0
Gross Profit: $-209 911 (0.00 %)
EPS: $-1.580
FY 2023
Revenue: $0
Gross Profit: $-209 911 (0.00 %)
EPS: $-1.580
FY 2022
Revenue: $0
Gross Profit: $-193 273 (0.00 %)
EPS: $-1.210

Financial Reports:

No articles found.

Eupraxia Pharmaceuticals Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators